FDA authorizes marketing of the first genetic test for Fragile X Syndrome Medical Dialogues Bureau25 Feb 2020 8:39 AMUS: The U.S. Food and Drug Administration has authorized marketing of the test to detect a genetic condition known as Fragile X Syndrome (FXS), the...
SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius Medical Dialogues Bureau25 Feb 2020 7:36 AMCalifornia: SoftBank's second Vision Fund has led a new $165 million funding round in California-based Karius, which markets a test that can quickly...
Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS Medical Dialogues Bureau25 Feb 2020 7:33 AM"With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
Aurobindo Pharma gets USFDA nod for Azithromycin 250 mg and 500 mg Medical Dialogues Bureau24 Feb 2020 8:52 AMNew Delhi: Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture and market Azithromycin tablets, used for the...
Coronavirus: Restrictions imposed on the export of medical equipment to China Medical Dialogues Bureau24 Feb 2020 6:59 AMNew Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations Medical Dialogues Bureau24 Feb 2020 6:48 AMChennai: Solara Active Pharma Science Limited (Solara), an active Pharmaceutical Ingredient provider has announced that the US Food and Drug...
Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations Medical Dialogues Bureau24 Feb 2020 6:41 AMMalaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...
USFDA approves Eli Lilly's Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient Medical Dialogues Bureau23 Feb 2020 6:30 AMNew indication reflects a distinct patient population in the REWIND study, including primary people with multiple cardiovascular risk factors but...
AIIMS director kickstarts three day International Conference at Delhi Pharmaceutical Sciences and Research University Medical Dialogues Bureau23 Feb 2020 6:30 AMNew Delhi: Delhi Pharmaceutical Sciences and Research University (DPSRU) is hosting a three day International Conference of Cardiovascular Sciences-...
FDA approves Lundbeck's intravenous migraine prevention drug Vyepti, to launch in April 2020 Medical Dialogues Bureau23 Feb 2020 6:00 AMDeerfield: Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) has been approved by the U.S. Food and Drug Administration (FDA) for the preventive...
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative Pain Medical Dialogues Bureau23 Feb 2020 4:00 AMSAN DIEGO : Heron Therapeutics, Inc,. a commercial-stage biotechnology company focused on improving the lives of patients by developing...
Strides Consumer forays into North India market Medical Dialogues Bureau22 Feb 2020 10:59 AMAs part of the foray, the company has launched two products -- Nixit, and oral nicotine replacement therapy (NRT) product, and Jointflex, a topical...
